Startups
Avesta76 Therapeutics is a startup biotech company focused on developing medicines that address the broad spectrum of cancer.
Overview
Location
United States, California, Los Angeles
Founders name
Arjun Awasthi, Ph.D.; Ian Akash Morrison
Persons 2
| Date | First Name | Last Name | Title | Location | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Ian Akash | Morrison | Co-Founder & CEO | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 14, 2022 | Back in the Manifold: George Church-founded protein therapeutics biotech tacks on $40M in series A funds | Almost two years after launching, George Church-founded Manifold Bio has raised a $40 million series A to continue development of its protein barcode system and advance a number of oncology programs. The latest haul, announced Thursday, wil... |
| May 3, 2022 | Biotech startup Ankere Therapeutics lands $10 million Seed round to tackle lung diseases | Biotech startup Ankere Therapeutics has raised $10 million in Seed capital to develop new therapies targeting inflammatory diseases, especially in the lungs. The funding round was co-led by IP Group and Brandon Capital, through Brandon BioC... |
| May 22, 2019 | Biotech company Chondrial Therapeutics has raised $25.8M for its Friedreich’s ataxia treatment | Eleven-person biotech company Chondrial Therapeutics just raised $25.8 million in a private stock sale to commercialize its treatment for people with the neurodegenerative movement disorder Friedreich’s ataxia. The funding will support Chon... |
| Nov 5, 2009 | US biotech investor Celtic Therapeutics gets $100m commitment, partnership from PPD | Celtic Therapeutics will focus on mid-stage drug development candidates that have progressed through human proof-of-conc |
Reviews 0
FAQ about Biotech
What has the press written about Biotech?
Parsers VC has collected 5 articles mentioning Biotech, among them “Back in the Manifold: George Church-founded protein therapeutics biotech tacks on $40M in series A funds” (Jul 14, 2022) and “Biotech startup Ankere Therapeutics lands $10 million Seed round to tackle lung diseases” (May 3, 2022).
Is Biotech still active?
Yes, Biotech is active; its latest activity on Parsers VC dates from Aug 8, 2022.